GPR142
GPR142 is a protein that in humans is encoded by the GPR142 gene. This gene is a member of the G protein-coupled receptor (GPCR) family, which is a large group of cell surface receptors that play a key role in cellular communication and signal transduction. GPR142 is predominantly expressed in the pancreas, particularly in the islets of Langerhans, and has been implicated in the regulation of insulin secretion.
Function[edit | edit source]
GPR142 is involved in the regulation of glucose metabolism by modulating insulin secretion from pancreatic beta cells in response to nutrient stimuli, such as amino acids. It is activated by aromatic amino acids, with tryptophan and phenylalanine being the most potent agonists. Upon activation, GPR142 couples with G proteins to initiate a signaling cascade that results in the release of insulin. This process is crucial for maintaining glucose homeostasis in the body.
Clinical Significance[edit | edit source]
Given its role in insulin secretion, GPR142 is of interest in the study of diabetes mellitus, a metabolic disorder characterized by high blood glucose levels due to inadequate insulin production or action. Agonists of GPR142 are being explored as potential therapeutic agents for the treatment of type 2 diabetes, as they could enhance insulin secretion in response to elevated blood glucose levels. However, the development of such treatments requires a thorough understanding of GPR142's function and regulation, as well as the long-term effects of its activation.
Research Directions[edit | edit source]
Research on GPR142 is focused on elucidating its exact signaling mechanisms, its role in glucose homeostasis, and its potential as a target for diabetes treatment. Studies are also investigating the receptor's expression in tissues other than the pancreas and its possible functions in these locations. Understanding the full spectrum of GPR142's physiological roles could open new avenues for the treatment of diabetes and possibly other metabolic disorders.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
